Literature DB >> 33189158

Lung cancer control in the UK hit badly by COVID-19 pandemic.

Elizabeth Gourd.   

Abstract

Entities:  

Year:  2020        PMID： 33189158     DOI： 10.1016/S1470-2045(20)30691-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.

Authors:  Doran Ksienski; Sapna Gupta; Pauline T Truong; Jeffrey Bone; Angela Chan; Deepu Alex; Jason Hart; Philip Pollock; Tiffany Patterson; Melissa Clarkson; Dushanthi Dissanayake; Eric Sonke; Mary Lesperance
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-14       Impact factor: 4.322

2.  Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China.

Authors:  Haijing Guan; Chunping Wang; Chen Chen; Sheng Han; Zhigang Zhao
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

3.  Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For.

Authors:  Michele Carbone; John Lednicky; Shu-Yuan Xiao; Mario Venditti; Enrico Bucci
Journal:  J Thorac Oncol       Date:  2021-01-07       Impact factor: 15.609

Review 4.  Severity of COVID-19 in patients with lung cancer: evidence and challenges.

Authors:  Antonio Passaro; Christine Bestvina; Maria Velez Velez; Marina Chiara Garassino; Edward Garon; Solange Peters
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

5.  Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.

Authors:  Rudolf M Huber; Milena Cavic; Anna Kerpel-Fronius; Lucia Viola; John Field; Long Jiang; Ella A Kazerooni; Coenraad F N Koegelenberg; Anant Mohan; Ricardo Sales Dos Santos; Luigi Ventura; Murry Wynes; Dawei Yang; Javier Zulueta; Choon-Taek Lee; Martin C Tammemägi; Claudia I Henschke; Stephen Lam
Journal:  J Thorac Oncol       Date:  2021-12-03       Impact factor: 15.609

Review 6.  Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance.

Authors:  Lawek Berzenji; Leonie Vercauteren; Suresh K Yogeswaran; Patrick Lauwers; Jeroen M H Hendriks; Paul E Van Schil
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.575

Review 7.  COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges.

Authors:  Simon Moubarak; Diala Merheb; Lynn Basbous; Nathalie Chamseddine; Maroun Bou Zerdan; Hazem I Assi
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.